SomaLogic, Inc.

Buy-side

Exclusive Financial Advisor, July 2022

SomaLogic, Inc.
Acquisition of Palamedrix, Inc.

SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. 

Palamedrix’s technology uses DNA-based biosensors that capture small molecules present in biological samples to pinpoint the presence of any analyte with single-molecule accuracy. The platform can organize and interrogate many millions of these biosensors on a surface to deliver comprehensive data and a complete view of a patient’s biochemistry from a single sample. 

More Like This

Apr 2023
$55 Million

Acquisition of all assets related to the REMI Robotic Navigation System from Fusion Robotics, LLC

Exclusive Financial Advisor

View Details >
Apr 2023

Acquisition and Financing of Shapiro Aesthetic Plastic Surgery & Skin Klinic

Exclusive Financial Advisor

View Details >
Nov 2022

Inspire Aesthetics, Inc., a Portfolio Company of Hidden Harbor Capital Partners, Has Acquired McCollough Plastic Surgery Clinic

Exclusive Financial Advisor

View Details >